DK1112083T3 - Behandling af mikrovaskulære angiopatier - Google Patents

Behandling af mikrovaskulære angiopatier

Info

Publication number: DK1112083T3
Authority: DK; Denmark
Prior art keywords: treatment; methods; angiopathies; microvascular; compositions
Prior art date: 1998-09-09

Application number

DK99946776T

Other languages

English (en)

Inventor

George F Schreiner

Richard J Johnson

Original Assignee

Univ Washington

Scios Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-09

Filing date

1999-09-09

Publication date

2004-03-08

1999-09-09 Application filed by Univ Washington, Scios Inc filed Critical Univ Washington

2004-03-08 Application granted granted Critical

2004-03-08 Publication of DK1112083T3 publication Critical patent/DK1112083T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A61K38/1866—Vascular endothelial growth factor [VEGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Immunology (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Diabetes (AREA)
Transplantation (AREA)
Pulmonology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Investigating Or Analysing Biological Materials (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DK99946776T 1998-09-09 1999-09-09 Behandling af mikrovaskulære angiopatier DK1112083T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date
US9969498P	1998-09-09	1998-09-09
US12640699P	1999-03-26	1999-03-26
US12661599P	1999-03-27	1999-03-27

Publications (1)

Publication Number	Publication Date
DK1112083T3 true DK1112083T3 (da)	2004-03-08

Family

ID=27378887

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK99968631T DK1109571T3 (da)	1998-09-09	1999-09-09	Fremgangsmåde til behandling af saltafhængig hypertension
DK99946776T DK1112083T3 (da)	1998-09-09	1999-09-09	Behandling af mikrovaskulære angiopatier

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK99968631T DK1109571T3 (da)	1998-09-09	1999-09-09	Fremgangsmåde til behandling af saltafhængig hypertension

Country Status (13)

Country	Link
US (3)	US6352975B1 (da)
EP (2)	EP1109571B1 (da)
JP (2)	JP2002532382A (da)
AT (2)	ATE253934T1 (da)
AU (2)	AU5910599A (da)
BR (2)	BR9913533A (da)
CA (2)	CA2340728C (da)
DE (2)	DE69915310T2 (da)
DK (2)	DK1109571T3 (da)
ES (2)	ES2211165T3 (da)
IL (2)	IL141686A0 (da)
PT (2)	PT1112083E (da)
WO (2)	WO2000013702A2 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR9913533A (pt) *	1998-09-09	2001-06-05	Scios Inc	Processos para tratar hipertensão e composições para uso nos mesmos
US6783954B2 (en) *	1999-03-05	2004-08-31	Compugen Ltd.	VEGF nucleic acid and amino acid sequences
IL148674A0 (en) *	1999-11-02	2002-09-12	Genentech Inc	Modulation of enos activity and therapeutic uses thereof
US7078382B1 (en)	1999-11-02	2006-07-18	Genentech, Inc.	Modulation of eNOS activity and therapeutic uses thereof
US20030129251A1 (en)	2000-03-10	2003-07-10	Gary Van Nest	Biodegradable immunomodulatory formulations and methods for use thereof
US7129222B2 (en) *	2000-03-10	2006-10-31	Dynavax Technologies Corporation	Immunomodulatory formulations and methods for use thereof
GB0008269D0 (en)	2000-04-05	2000-05-24	Astrazeneca Ab	Combination chemotherapy
JP4689956B2 (ja)	2001-08-01	2011-06-01	ユニバーシティオブブリストル	増殖因子イソ型
WO2003015605A2 (en) *	2001-08-20	2003-02-27	University Of Virginia Patent Foundation	Use of s-nitrosothiol signaling to treat disordered control of breathing
US7981863B2 (en) *	2001-09-19	2011-07-19	Neuronova Ab	Treatment of Parkinson's disease with PDGF
US7795213B2 (en)	2001-12-13	2010-09-14	Posco	Methods of contacting β amyloid protein with VEGF
US20030171556A1 (en) *	2001-12-13	2003-09-11	Chi-Bom Chae	Beta-amyloid binding factors and inhibitors thereof
US7335362B2 (en)	2002-07-19	2008-02-26	Beth Israel Deaconess Medical Center	Methods of treating pre-eclampsia or eclampsia
JP2006068401A (ja) *	2004-09-03	2006-03-16	Kyushu Institute Of Technology	人工血管
CA2604441A1 (en) *	2005-04-12	2006-10-19	Intradigm Corporation	Composition and methods of rnai therapeutics for treatment of cancer and other neovascularization diseases
US7893244B2 (en) *	2005-04-12	2011-02-22	Intradigm Corporation	Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases
WO2007026820A1 (ja) *	2005-08-31	2007-03-08	National University Corporation Kagawa University	D-アロースによる高血圧、心肥大発症抑制効果の利用
US8927511B2 (en) *	2008-12-04	2015-01-06	Curna, Inc.	Treatment of vascular endothelial growth factor (VEGF) related diseases by inhibition of natural antisense transcript to VEGF
GB0921525D0 (en) *	2009-12-08	2010-01-27	Isis Innovation	Product and method
US11229682B2 (en)	2017-03-30	2022-01-25	Wake Forest University Health Sciences	Methods of treatment for kidney disease
CN113418940B (zh) *	2021-06-24	2023-03-14	电子科技大学	一种基于x射线示踪颗粒的检测方法及检测装置

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4456550A (en)	1982-11-22	1984-06-26	President And Fellows Of Harvard College	Vascular permeability factor
US5240848A (en)	1988-11-21	1993-08-31	Monsanto Company	Dna sequences encoding human vascular permeability factor having 189 amino acids
CA2050318C (en)	1989-03-24	2011-04-12	Napoleone Ferrara	Endothelial cell growth factor, methods of isolation and expression
US5332671A (en)	1989-05-12	1994-07-26	Genetech, Inc.	Production of vascular endothelial cell growth factor and DNA encoding same
US5219739A (en) *	1989-07-27	1993-06-15	Scios Nova Inc.	DNA sequences encoding bVEGF120 and hVEGF121 and methods for the production of bovine and human vascular endothelial cell growth factors, bVEGF120 and hVEGF121
US5194596A (en) *	1989-07-27	1993-03-16	California Biotechnology Inc.	Production of vascular endothelial cell growth factor
US5240714A (en) *	1989-08-29	1993-08-31	Rof Jose M S	Non-digoxin-like Na+, K+ -ATPase inhibitory factor
US5318957A (en) *	1992-09-02	1994-06-07	The United States Of America As Represented By The Department Of Health And Human Services	Method of stimulating angiogenesis
PL189744B1 (pl) *	1996-11-01	2005-09-30	Eurogene Ltd	Zastosowanie środka będącego białkiem VEGF oraz wszczep do stosowania leczniczego
US6485942B1 (en) *	1997-02-14	2002-11-26	Genentech, Inc.	Variants of vascular endothelial cell growth factor having altered pharmacological properties, and recombinant methods of production
BR9913533A (pt) *	1998-09-09	2001-06-05	Scios Inc	Processos para tratar hipertensão e composições para uso nos mesmos

1999
- 1999-09-09 BR BR9913533-7A patent/BR9913533A/pt not_active Application Discontinuation
- 1999-09-09 DK DK99968631T patent/DK1109571T3/da active
- 1999-09-09 US US09/392,932 patent/US6352975B1/en not_active Expired - Lifetime
- 1999-09-09 WO PCT/US1999/020480 patent/WO2000013702A2/en not_active Ceased
- 1999-09-09 IL IL14168699A patent/IL141686A0/xx unknown
- 1999-09-09 ES ES99946776T patent/ES2211165T3/es not_active Expired - Lifetime
- 1999-09-09 DE DE69915310T patent/DE69915310T2/de not_active Expired - Fee Related
- 1999-09-09 CA CA002340728A patent/CA2340728C/en not_active Expired - Fee Related
- 1999-09-09 CA CA002340320A patent/CA2340320C/en not_active Expired - Fee Related
- 1999-09-09 BR BR9913564-7A patent/BR9913564A/pt not_active Application Discontinuation
- 1999-09-09 AU AU59105/99A patent/AU5910599A/en not_active Abandoned
- 1999-09-09 EP EP99968631A patent/EP1109571B1/en not_active Expired - Lifetime
- 1999-09-09 DE DE69912815T patent/DE69912815T2/de not_active Expired - Fee Related
- 1999-09-09 PT PT99946776T patent/PT1112083E/pt unknown
- 1999-09-09 WO PCT/US1999/020481 patent/WO2000013703A2/en not_active Ceased
- 1999-09-09 EP EP99946776A patent/EP1112083B1/en not_active Expired - Lifetime
- 1999-09-09 AT AT99946776T patent/ATE253934T1/de not_active IP Right Cessation
- 1999-09-09 JP JP2000568511A patent/JP2002532382A/ja active Pending
- 1999-09-09 IL IL14168799A patent/IL141687A0/xx unknown
- 1999-09-09 PT PT99968631T patent/PT1109571E/pt unknown
- 1999-09-09 DK DK99946776T patent/DK1112083T3/da active
- 1999-09-09 AU AU60285/99A patent/AU6028599A/en not_active Abandoned
- 1999-09-09 ES ES99968631T patent/ES2216630T3/es not_active Expired - Lifetime
- 1999-09-09 JP JP2000568510A patent/JP2002524421A/ja active Pending
- 1999-09-09 AT AT99968631T patent/ATE260675T1/de not_active IP Right Cessation
2002
- 2002-02-26 US US10/083,817 patent/US20020193288A1/en not_active Abandoned
2003
- 2003-12-31 US US10/749,706 patent/US20040224885A1/en not_active Abandoned

Also Published As

Publication number	Publication date
BR9913564A (pt)	2001-05-22
DE69912815D1 (de)	2003-12-18
WO2000013702A9 (en)	2000-10-19
ES2216630T3 (es)	2004-10-16
DE69915310D1 (de)	2004-04-08
ATE253934T1 (de)	2003-11-15
WO2000013703A9 (en)	2000-06-02
WO2000013703A3 (en)	2000-07-06
EP1112083A2 (en)	2001-07-04
IL141687A0 (en)	2002-03-10
CA2340320A1 (en)	2000-03-16
US20040224885A1 (en)	2004-11-11
JP2002524421A (ja)	2002-08-06
EP1109571B1 (en)	2004-03-03
DK1109571T3 (da)	2004-06-21
EP1109571A2 (en)	2001-06-27
ES2211165T3 (es)	2004-07-01
JP2002532382A (ja)	2002-10-02
PT1109571E (pt)	2004-05-31
CA2340728A1 (en)	2000-03-16
IL141686A0 (en)	2002-03-10
AU5910599A (en)	2000-03-27
ATE260675T1 (de)	2004-03-15
WO2000013702A3 (en)	2000-09-08
CA2340320C (en)	2006-11-14
US20020193288A1 (en)	2002-12-19
AU6028599A (en)	2000-03-27
PT1112083E (pt)	2004-03-31
CA2340728C (en)	2007-11-27
US6352975B1 (en)	2002-03-05
WO2000013702A2 (en)	2000-03-16
EP1112083B1 (en)	2003-11-12
WO2000013703A2 (en)	2000-03-16
BR9913533A (pt)	2001-06-05
DE69915310T2 (de)	2005-03-10
DE69912815T2 (de)	2004-10-21

Publication	Publication Date	Title
DK1112083T3 (da)	2004-03-08	Behandling af mikrovaskulære angiopatier
BR9707819A (pt)	1999-07-27	Imunogenos peptidicos
ATE208382T1 (de)	2001-11-15	Konjugate von cis-docosahexaensäure und paclitaxel
DK1039912T3 (da)	2002-10-28	Angiostatiske midler og præparater til behandling af GLC1A-glaukom
DK0914116T3 (da)	2000-11-20	Kompositstoffer omfattende konjugater af cis-docosahexaensyre og Taxotere
ATE295355T1 (de)	2005-05-15	Trisubstituierte 1,3,5-triazine derivate zur behandlung von hiv infektionen
DK0914102T3 (da)	2006-01-09	Præparater og fremgangsmåder til behandling eller forebyggelse af syddomme i legemskanaler
ATE367158T1 (de)	2007-08-15	Quinazolinenon-enthaltende pharmazeutische zusammensetzungen zur verhütung von gefässneubildung und zur behandlung von bösartigen neubildungen
WO1997045137A8 (en)	2001-02-01	Methods and compositions useful for inhibition of angiogenesis
BR0107691A (pt)	2005-03-22	Sapogeninas substituìdas e seu uso
DK0889886T5 (da)	2003-02-24	Hidtil ukendte, i 6-stilling substituerede phenanthridiner
TR200200821T2 (tr)	2002-06-21	5-Beta-sapojenin ve pseudosapojenin türevleri ve bunların bunama tedavisinde kullanımı.
DK0967987T3 (da)	2003-09-22	Sammensætning til behandling af tumorer indeholdende hajbruskekstrakter og anitneoplastiske stoffer
WO2001030333A3 (en)	2002-02-07	Tissue factor antagonists and methods of use thereof
ATE297198T1 (de)	2005-06-15	Zusammensetzungen und verfahren zur verbesserung der integrität von angegriffenen körperpassagewegen und höhlen
TR199801988T2 (xx)	2000-08-21	Kalp yetmezli�inin endotelin antagonistleri ile tedavisi i�in y�ntem.
DK1303294T3 (da)	2006-10-30	Fremgangsmåde til behandling af instabil angina pectoris
DK1143917T3 (da)	2004-06-01	Antikonvulsive derivater egnet til behandling af posttraumatisk stresssygdom
DE60134885D1 (de)	2008-08-28	Antiangiogene polypeptide
EP1447089A3 (en)	2004-12-15	Methods of treating hypertension and compositions for use therein
ATE292970T1 (de)	2005-04-15	Topische zusammensetzung enthaltend brucin und ihre verwendung zur behandlung von hautschäden
UA32314A (uk)	2000-12-15	Спосіб лікування некротичного панкреатиту